© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Folks chasing better memory and sharper thinking have looked at lab benches for decades, not just leafy greens or crossword puzzles. In post-war Europe, scientists stumbled onto meclofenoxate hydrochloride while searching for ways to help people recover from strokes and age-related decline. The Soviets invested heavily in nootropic research, and by the 1960s, meclofenoxate—often labeled as Centrophenoxine—landed in pharmacies as a possible tool for older adults losing touch with words and memories. Early publications in French and Soviet journals outlined improvements in recall, attention, and even basic activities that tend to slip with age. It didn't earn a miracle reputation everywhere, but its story wound through aging clinics and neurochemistry labs alike. Clinical interest still pulses today, driven by aging populations and greater acceptance of cognitive enhancement as a legitimate field of research.
Meclofenoxate hydrochloride comes as a white, almost crystalline powder dissolving easily in water, making it easy to measure and blend into tablets or capsules. Most suppliers package it as a bulk powder for pharmacy compounding, but you’ll also see clear gelatin capsules and solutions for researchers. Labs and companies stamp product sheets with both generic and trade designations: Centrophenoxine, Lucidril, and sometimes just MCF. Despite shifting supply chains, the base product tends not to waver in appearance or behavior, which is key for anyone tracking batch consistency or dosing accuracy.
This powder isn’t remarkable to look at—odorless, white, not sticky or oily. With a molecular formula of C12H17ClNO3 and a molecular weight just over 259 grams per mole, it settles easily in a lab scale. Its melting point hovers between 164-168°C. In water or saline it dissolves well—a point appreciated by clinicians prepping infusions. Chemically, it marries dimethylaminoethanol (DMAE) with parachlorophenoxyacetic acid, creating an ester that speeds across cell membranes faster than DMAE alone. Regulatory databases such as PubChem or ChemSpider catalog the molecule under several entries, reflecting a wide net of research interest.
Quality control matters here because the margin for contamination or incorrect dosing remains thin in brain-related supplements. High-purity batches (often >98%) top ingredient lists for clinical trials, with identity confirmed by infrared spectra and HPLC fingerprinting. Commercial samples get labeled by content percentage, batch code, and shelf-life—often two years under dry, cool storage. Labels bear statutory warnings—keep out of reach from kids, seek advice if on medication, not for pregnant or nursing women—drawn from a pool of best practices in pharma labeling. Trusted suppliers sign off each order with a certificate of analysis, sometimes tacking on microbial load counts and residual solvent measures to ease import concerns.
Chemists synthesize this molecule by mixing DMAE with parachlorophenoxyacetic acid under acidic conditions, usually refluxing in ethanol with hydrochloric acid. This yields the hydrochloride salt—a more stable, easily handled version for trade. Shifts in input purity or process temperature shape the ultimate product, so experienced teams dial in every parameter: pH, solvent, mixing speed. Purification cycles follow, stripping unreacted raw materials or byproducts so only pure, active meclofenoxate hydrochloride remains. From mixing tank to drying oven, quality checkpoints catch any slip-ups—a lesson hard-won by pharmaceutical makers who can’t afford customer complaints or failed stability tests.
Once formed, meclofenoxate’s ester bond stands up well to storage, only breaking down under strong base or extended heat. Under metabolic conditions, the human liver splits it into DMAE and parachlorophenoxyacetic acid, both of which play roles in brain metabolism and neurotransmitter support. Research teams have tinkered with side chains or salt forms, chasing longer shelf life or improved absorption. Some explore coformulations with antioxidants, aiming to slow auto-oxidation and preserve potency during shipping—a persistent headache for stores in hot climates. Chemists debate the merits of tweaks, since every subtle change might tip the balance between benefit and new, unknown risks.
Pharmacists and researchers know this stuff goes by several banners. Centrophenoxine still turns up on old medical charts, reflecting its spearhead status in early research. Lucidril pops up in European product listings, particularly in France and Germany. Chemical supply catalogs write Meclofenoxate Hydrochloride in bold, but synonyms such as 2-(Dimethylamino)ethyl (4-chlorophenoxy)acetate hydrochloride or DMAE p-chlorophenoxyacetate turn up in regulatory filings. Anyone sifting through literature or ordering samples learns to scan for all variants just to avoid confusion or accidental duplication.
Personal safety starts with the bottle. Dust from the powder can irritate the skin, eyes, and lungs, so professional labs keep gloves and dust masks ready when weighing or mixing. Safety data sheets peg it as having low acute toxicity, but still recommend careful handling and frequent hand washing. In bulk environments, air handling systems snatch up airborne particles. Technicians store the chemical in cool, dry rooms, away from acidic or basic substances, and double-check expiration dates before each use. Shipping regulations treat it as non-hazardous, but country-specific laws demand tracking and documentation, especially for research or pharmaceutical batches. Anyone sourcing it overseas must check for extra certifications—GMP, ISO, or local health ministry approval—ensuring it meets modern production standards.
Hospitals and clinics use meclofenoxate in off-label treatments for age-related memory issues, with a longer history in Eastern Europe and Asia than in North America. Some neurologists offer it alongside physical therapy for post-stroke patients, and off-label use pops up among healthy adults seeking sharper recall or mental stamina. Research studies probe its effects across animal and human trials, measuring cognitive scores and metabolic markers. Consumer supplement brands ride the wave of interest in “nootropics,” although regulatory scrutiny varies widely between countries. Outside clinics, aging wellness centers market it as part of comprehensive brain health programs, pairing it with lifestyle interventions and other vitamins to round out offerings.
The science around meclofenoxate is more robust than many new-age memory pills crowding online stores. Early French and Russian studies tracked patients over months, showing mild improvement in recall and day-to-day tasks. Newer work explores its power as an antioxidant, searching for ways to slow brain aging by reducing free radical buildup. Aging dogs, rats, and monkeys show improved learning after treatment, stirring hope among researchers studying neurodegenerative diseases. Clinical research labs sequence patient DNA, checking if certain people respond better than others—a nod to the realities of personalized medicine. Some teams weigh long-term dosing risks, while others chase ways to boost bioavailability with advanced delivery systems. The hunt for unbiased, large-scale, double-blind trials continues, emphasizing the difference between promising lab results and real-world application.
All chemicals for the brain earn heavy scrutiny. Acute toxicity tests in animals reveal wide safety margins, and people taking standard doses rarely report severe problems. Some complain about mild headaches, digestive upset, or jitteriness, but serious side effects tend to cluster around extreme overdoses. Chronic studies stretch over months, searching for subtle changes in liver enzymes, kidney function, or blood chemistry—so far, no devasting findings in typical users. Regulators stay alert for rare allergic reactions or interactions with existing medication, especially antidepressants or anti-seizure drugs. Developers keep a close eye on continual updates from animal and cell studies, knowing that discoveries about long-term effects will inform future usage guidelines and labeling claims.
People live longer, so interest in cognitive health climbs year after year. Research teams pour grant money into brain aging and dementia solutions, putting molecules like meclofenoxate back in the spotlight. Some believe advanced formulations using nanoparticles or targeted delivery could help steer the chemical more directly where it’s needed in the brain. Neuroimaging and gene sequencing sharpen the focus, making way for treatments customized by individual biology. Better monitoring tools will help spot subtle benefits or side effects sooner. In my view, anyone following this field should keep one eye on regulatory developments and the other on well-designed clinical trials. Only careful, painstaking work, built around real-world outcomes, can determine the right role for meclofenoxate hydrochloride in protecting memory and boosting cognitive performance as society faces the realities and challenges of an aging population.
Meclofenoxate Hydrochloride, which many folks know as centrophenoxine, sits on pharmacy shelves mostly as a so-called "nootropic." People grab it with hopes of clearer memory, better focus, and sometimes even a brighter mood. For decades, older adults have used it to try to stave off forgetfulness or that lingering mental fog that seems to come with age. Researchers in Europe first explored meclofenoxate for dementia and Alzheimer's, thinking it might improve mental function by helping the brain use oxygen and glucose more efficiently.
The science goes back to the 1950s. Early tests showed meclofenoxate might help clear waste byproducts—like lipofuscin, which some scientists connect to aging brains. Some studies suggested that folks who took the supplement scored better on memory tests or felt more alert.
I watched an older neighbor try meclofenoxate on his own after reading about it online. He told me his mind just felt "quicker" after a week or two. He remembered more names and details from stories he’d heard long ago. Still, those are personal stories and not everyone gets the same results. Medical research doesn’t always paint such a clear picture. The data can be hit or miss, with some studies showing benefits and others finding barely any difference compared to a sugar pill.
Living in a world that prizes productivity and mental sharpness, it's no wonder supplements like meclofenoxate attract attention. I can remember losing my own train of thought in stressful periods and wishing for a shortcut to clearer thinking. College students, busy professionals, and aging adults all look for an edge, hoping supplements can make up for lack of sleep or keep them sharp as the years roll by.
Doctors who know this supplement urge caution. Meclofenoxate can cause headaches, insomnia, or even confusion, mostly in people taking high doses. For folks with high blood pressure, it can push numbers higher. Some countries only let doctors prescribe it, since the FDA hasn’t approved it in the U.S. Before picking up any supplement, it makes sense to talk with a healthcare provider. Not every product sold online comes with quality controls or certainty about its ingredients.
Researchers continue studying compounds that promise to help memory or brain health. Few of them become breakthrough treatments. The ones worth trusting are usually tested in large, controlled studies with real people—not just lab animals. Meclofenoxate had its moment in the spotlight, but nothing beats regular sleep, a healthy diet, and staying mentally engaged when it comes to long-term brain health.
While supplements offer hope, simple habits still make the biggest difference. Eating more vegetables, moving your body daily, skipping cigarettes, and staying curious about the world pay off in ways no pill can match. If you're worried about memory or mental sharpness, reach out to a medical professional instead of relying on stories or quick fixes.
Meclofenoxate Hydrochloride, sometimes called centrophenoxine, has caught attention for its potential to sharpen thinking and improve memory. I’ve seen students and older adults talk about this compound with hope in online forums and support groups—many looking for a mental edge or a boost in clarity. It’s easy to get excited about something that might help with brain fog or age-related memory problems. Risks, though, need a clear look before anyone tries it.
A lot of people who try meclofenoxate notice some mild effects. They speak about headaches early on. I’ve watched health communities trade stories about feeling restless or wired after taking it. That alertness can move into sleep trouble if people take it too late in the day. Dry mouth comes up fairly often, too. In my research, I keep hearing that stomach irritation happens for a few—nausea, stomach cramps, and an upset gut have all popped up.
Based on published case reviews and what I’ve seen in support chats, older adults and those who take higher doses tend to report more problems. Folks with high blood pressure or kidney issues tell of feeling flushed, lightheaded, or seeing their symptoms get worse. Some meclofenoxate users have said they feel overstimulated, almost jittery, which makes sense knowing this drug works on brain chemicals that keep people alert.
Most people don’t see major problems, but medical journals and adverse event reports have flags worth knowing about. Allergic reactions are rare but real; rashes, swelling, or trouble breathing should get immediate medical help. Over the years, one or two people have shared experiences of confusion or agitation when starting high doses. No one wants to feel out of control, especially if already anxious.
People often feel pressure to try something—especially after seeing a post about big improvements in memory or focus. I’ve learned that drugs affecting the brain rarely give the same result to everyone. What helped my neighbor’s college roommate could send someone else into days of headaches or jitteriness. Quality varies across pills sold online. If a label skips key information, that’s trouble in my eyes. I encourage friends to look up where a supplement comes from and question why a prescription exists in some countries but not in others.
Anyone thinking about meclofenoxate should talk to a health professional. Even smart, careful people miss key things about drug interactions or pre-existing conditions. People who notice side effects should lower their dose or stop until they speak with a doctor. A reliable pharmacist can help track how it might mix with medicines for blood pressure, diabetes, or depression. Keeping a journal helps too—writing down side effects and benefits, so conversations with professionals stay focused.
Every drug carries some risks—even those meant to boost brainpower. I trust stories from people who share honestly, and I look closely at peer-reviewed science for patterns. Those who take their health into their own hands should respect those signals, ask questions, and not chase claims that sound too good to be true. Health always deserves cautious curiosity, not reckless optimism.
Meclofenoxate Hydrochloride, often found on supplement shelves as Centrophenoxine, brings a reputation for cognitive enhancement. Decades of research and personal observation from those in neurology offer a mixed bag of results. Many adults attracted to sharper memory or improved mental focus have given it a closer look. Before jumping in, it’s important to highlight that the FDA doesn’t recognize this compound for any specific prescription use in the United States. That should give anyone pause before picking up a bottle.
Dosing always draws the attention of those serious about health, and for good reason. The usual range, based on studies and anecdotal reports, circles around 250mg to 1000mg per day, often split into two daily doses. Higher amounts occasionally appear in research, but those scenarios always come under the watchful eyes of medical professionals. For anyone looking to try it on their own, sticking to the lower end keeps things safer, starting at 250mg, and only increasing slowly.
Eating or fasting doesn’t make a big difference for absorption, but many users pick morning and early afternoon to avoid interfering with sleep. Experience shows staying consistent with timing leads to more predictable effects.
No smart pill comes without risks. Meclofenoxate Hydrochloride’s main side effects include headaches, nausea, and restlessness. People with high blood pressure or a history of seizure disorders should remain especially careful. In rare cases, high doses have triggered agitation or insomnia.
Mixing it with other supplements or drugs—especially other stimulants, antidepressants, or cholinergic compounds—raises the odds of unwanted side effects. Medical experts have long warned against stacking cognitive enhancers without a full grasp of the consequences.
Doctors and pharmacists carry direct experience dealing with the fallout when dosing goes wrong. Before considering meclofenoxate, a conversation with a healthcare provider makes all the difference. This goes double for anyone dealing with chronic illness or taking prescription medication. Trusting internet stories or supplement advertisements won’t provide the same grounding as speaking to a real professional with experience in pharmacology or neurology.
Manufacturers carry a responsibility to label clearly and honestly, something not all supplement brands follow through on. If a product’s packaging looks vague or features grandiose claims, it pays to look elsewhere. Supplements with third-party certifications—such as NSF or USP—often provide more reliable dosing information and better quality control.
Tracking changes with a journal helps reveal whether any improvements appear or side effects creep in. Making sense of personal experience often leads to far better choices than chasing quick fixes or relying on crowd-sourced advice. Sharing this information with a healthcare provider helps them flag any warning signs that might otherwise slip by.
Approaching meclofenoxate hydrochloride with respect means starting low, paying attention to the body’s signals, and relying on professional advice. Supplements in this space carry promise, but real safety comes from knowledge, accountability, and cautious dosing—not from chasing the latest online trends.
Meclofenoxate Hydrochloride, known to some as centrophenoxine, has found a niche among people searching for sharper memory or a mental boost. As someone who cares about brain health and pays close attention to research, I’ve seen old studies claim this compound could help with age-related memory loss. Others bring up possible benefits for folks looking to preserve their mental edge as they get older.
Researchers started testing meclofenoxate back in the 1950s. It’s a mix of dimethylaminoethanol (DMAE) and p-chlorophenoxyacetic acid. People hoped it might improve brain energy or choline levels—nutrients linked to memory and learning. Some early studies suggested meclofenoxate might help elderly patients with mild cognitive decline feel more alert. Animal experiments hinted at extra antioxidant support, which caught my attention after seeing how much chronic oxidative stress affects the brain over time.
Most of the buzz comes from small clinical trials or animal research, not from massive, recent studies on humans. There’s been no concrete proof that healthy people see big benefits. No government health agency has approved it for long-term treatment of dementia or Alzheimer’s. Doctors in Europe sometimes tried it for older patients with age-associated cognitive changes, but those reports come from decades ago.
Safety comes first, especially with something meant for weeks, months, or even years. Based on available studies, short-term use of meclofenoxate at suggested doses did not cause severe side effects in most older adults. Mild headaches, digestive discomfort, insomnia, and restlessness cropped up occasionally, matching my own experience reading reviews and forums where some users report feeling jittery. Higher doses or mixing with other stimulants could make things worse.
One big problem: we lack large, modern, long-term studies on meclofenoxate. Researchers usually only tracked patients for a few months. Long-term impacts on the liver, kidneys, or heart remain mostly unknown. Another worry—DMAE, one of its main ingredients, sometimes interacts with medications or certain health issues, including seizure disorders and bipolar conditions.
Those who want to try nootropics often read scattered advice online. But user reports only go so far. No one can guarantee another person won’t develop side effects after months or years. Not all supplements sold contain pure ingredients, and labels may mislead, given weak regulations in many countries.
From my perspective, long-term safety questions should push people toward caution. If someone is thinking about trying meclofenoxate for months or years, a talk with a licensed doctor or pharmacist makes sense, especially for those taking other drugs or with health challenges. Looking at alternatives, usual brain health basics—regular movement, sleep, social interaction, and a consistent routine—bring solid results without the same risks.
Meclofenoxate has a long and complicated history in research circles, but gaps remain in our understanding of its effects over long stretches. People hoping for safer aging or more mental clarity deserve transparent data, not just anecdotes or marketing promises. Anyone making personal health choices should seek evidence, trust medical professionals, and remember that no pill replaces habits proven to support brain health.
Anyone who has stood in a pharmacy holding a new prescription knows the feeling—there’s always a bit of concern about how it will mix with other meds at home. Meclofenoxate hydrochloride has attracted attention for its claimed cognitive benefits, so it’s fair to ask if it plays nicely with other drugs.
Personal experience has taught me that the most overlooked part of starting a new supplement or medication is the honest conversation with healthcare providers. I learned the hard way: even basic vitamins can tangle up with other meds, causing unexpected side effects or reducing their impact. Meclofenoxate, often marketed under the name Centrophenoxine, has a chemical structure with the potential to affect the brain’s neurotransmitter levels, especially acetylcholine. That stands out for anyone taking other central nervous system meds.
People on antidepressants, antipsychotics, epilepsy treatments, or even certain antihistamines should pay attention. Some antidepressants influence acetylcholine in the brain. Combining these with meclofenoxate could push neurotransmitter levels out of balance, leading to headaches, confusion, or more serious central nervous system effects. There’s not a long list of controlled clinical studies mapping every potential interaction. Much of what we know comes from case reports and the underlying science of how these drugs behave in the body.
Meclofenoxate may also affect blood pressure. If someone takes blood pressure medications or has a history of hypertension, stacking these drugs might lead to unpredictable swings. People on anticoagulants, such as warfarin, have to double-check with their doctor, since changes in mental alertness could mask early signs of internal bleeding or other side effects.
In an era with thousands of health forums and social media groups, it gets tempting to trust “success stories” or anecdotal advice. But quality information comes from peer-reviewed studies, pharmacists, and physicians. According to the U.S. National Library of Medicine, meclofenoxate is not approved by the FDA for any medical use in the United States. That brings up another issue—quality control. Not every batch sold online goes through the same rigorous checks as prescription medications. People have reported inconsistent dosing and possible contamination when sourcing the supplement from overseas suppliers.
Open conversation with a healthcare provider makes a real difference. Bring a complete list of all medications and supplements to every appointment. Electronic health records flag many major interactions, but supplements like meclofenoxate often slip under the radar. Reporting any changes in mood, sleep, cognition, or cardiovascular health to a clinician helps catch issues early. Pharmacies keep up-to-date interaction checkers—no harm in asking, and a few minutes of double-checking can prevent major problems down the line.
Some folks choose to track supplements and medications in a notebook or an app, sharing updates with their healthcare team regularly. That approach can spot subtle patterns that doctors may miss in a quick office visit. In my own life, I’ve avoided headaches—literally and figuratively—by being proactive and not skipping on sharing my supplement list, no matter how minor something seems.
It takes real effort to stay informed in a world full of bold supplement claims. Meclofenoxate blends pharmaceutical science with the unpredictability of off-label use. A little caution, honest dialogue, and ongoing attention to changes in health keep people safer. The risks of mixing this supplement with other drugs don’t always show up in big red letters on the label—but they’re real, and worth respecting.
| Names | |
| Preferred IUPAC name | 2-(4-chlorophenoxy)-N-morpholino-N-methylacetamide hydrochloride |
| Other names |
Centrophenoxine Lucidril Analux |
| Pronunciation | /ˌmɛk.ləˈfɛn.əˌksæt ˌhaɪ.drəˈklɔː.raɪd/ |
| Identifiers | |
| CAS Number | 3685-84-5 |
| Beilstein Reference | 96979 |
| ChEBI | CHEBI:131266 |
| ChEMBL | CHEMBL2104386 |
| ChemSpider | 12022 |
| DrugBank | DB09021 |
| ECHA InfoCard | echa.europa.eu/substance-information/-/substanceinfo/100.053.437 |
| EC Number | 200-252-8 |
| Gmelin Reference | 108203 |
| KEGG | C11188 |
| MeSH | D008477 |
| PubChem CID | 3034402 |
| RTECS number | OM2625000 |
| UNII | 1LFM8UAE2Z |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C12H17ClNO2 |
| Molar mass | 339.82 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -2.0 |
| Acidity (pKa) | 4.1 |
| Basicity (pKb) | 5.5 |
| Magnetic susceptibility (χ) | -74.0 × 10^-6 cm³/mol |
| Refractive index (nD) | 1.581 |
| Dipole moment | 5.09 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 322.1 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | Std enthalpy of combustion (ΔcH⦵298) of Meclofenoxate Hydrochloride: "-6534 kJ/mol |
| Pharmacology | |
| ATC code | N06BX06 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | 🧠⚠️🚫🤰🚗💊 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes serious eye irritation. |
| Precautionary statements | P264, P270, P280, P301+P312, P305+P351+P338, P337+P313, P501 |
| Flash point | > 181.6 °C |
| Lethal dose or concentration | LD50 (oral, rat): 650 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Meclofenoxate Hydrochloride: "3700 mg/kg (oral, rat) |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 330 mg daily |
| IDLH (Immediate danger) | IDLH not established |
| Related compounds | |
| Related compounds |
Centrophenoxine DMAE (Dimethylaminoethanol) Choline Piracetam Oxiracetam Aniracetam |
